Bionic eye implant offers hope for blindness from dry AMD
NCT ID NCT03392324
First seen Apr 09, 2026 · Last updated May 13, 2026 · Updated 4 times
Summary
This early study tests a new retinal implant called PRIMA in 5 people with advanced dry age-related macular degeneration (AMD), a leading cause of vision loss. The implant is designed to replace damaged cells in the eye and help restore central vision. The main goals are to check if the device is safe and if it can improve the ability to see details up close.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bascom Palmer Eye Institute
Miami, Florida, 33136, United States
-
Byers Eye Institute-Stanford University
Palo Alto, California, 94303, United States
-
UPMC Eye Center
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.